Evozyne

Evozyne uses generative AI and high-throughput biology to design, build, and validate therapeutic proteins tailored to immune-mediated diseases with high unmet need.

Evozyne collaborates with technology, biopharma, and global research organizations to validate its generative AI platform and advance engineered protein therapeutics for immune-mediated diseases.

Evozyne integrates generative AI with high-throughput biology to design and build therapeutic proteins with properties nature never delivered. This creates a fast, iterative, and increasingly predictive discovery engine.

Evozyne’s publications describe research on generative AI producing proteins with properties beyond those of natural evolution.

The company lists careers@evozyne.com as a contact for information about open positions.

Andrew Ferguson leads Evozyne’s computational, machine learning, and software development efforts. He is an associate professor at the University of Chicago and researches self-assembling materials, macromolecular folding, and antiviral therapies.

Arjun Rallapalli leads Evozyne’s operations and execution strategy, overseeing execution across R&D, business operations, and corporate strategy. Before Evozyne, Rallapalli was a manager at McKinsey & Company and began a career at GE Healthcare.

The company designs and builds engineered protein therapeutics with its AI-native platform for immune-mediated disease treatment.

Evozyne uses generative models and high-throughput biology to design new proteins with mechanisms not found in nature, tailored to complex immune diseases.

Evozyne was founded by Paragon Biosciences and is well funded by additional top-tier investors.

Evozyne’s AI-native platform creates mechanisms not produced by natural evolution and aims to accelerate development from concept to clinic. The company focuses on immune-mediated diseases with high unmet need.

Evozyne, Inc. respects the privacy of information relating to individuals and values the confidence of its employees, customers, vendors, and partners.

GitHubRepository owner